Neuroprotective Effects of Resveratrol in Ischemic Brain Injury
- Autores
- Machado, Noelia Daiana; Villena Armas, Gorka; Fernández, Mariana Adela; Grijalvo, Santiago; Díaz Díaz, David
- Año de publicación
- 2021
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Cerebral ischemia represents the third cause of death and the first cause of disability inadults. This process results from decreasing cerebral blood flow levels as a result of the occlusionof a major cerebral artery. This restriction in blood supply generates low levels of oxygen andglucose, which leads to a decrease in the energy metabolism of the cell, producing inflammation, andfinally, neurological deterioration. Currently, blood restoration of flow is the only effective approachas a therapy in terms of ischemic stroke. However, a significant number of patients still have apoor prognosis, probably owing to the increase in the generation of reactive oxygen species (ROS)during the reperfusion of damaged tissue. Oxidative stress and inflammation can be avoided bymodulating mitochondrial function and have been identified as potential targets for the treatmentof cerebral ischemia. In recent years, the beneficial actions of flavonoids and polyphenols againstcerebrovascular diseases have been extensively investigated. The use of resveratrol (RSV) has beenshown to markedly decrease brain damage caused by ischemia in numerous studies. According toin vitro and in vivo experiments, there is growing evidence that RSV is involved in several pathways,including cAMP/AMPK/SIRT1 regulation, JAK/ERK/STAT signaling pathway modulation, TLR4signal transduction regulation, gut/brain axis modulation, GLUT3 up-regulation inhibition, neuronalautophagy activation, and de novo SUR1 expression inhibition. In this review, we summarize therecent outcomes based on the neuroprotective effect of RSV itself and RSV-loaded nanoparticlesin vitro and in vivo models focusing on such mechanisms of action as well as describing the potentialtherapeutic strategies in which RSV plays an active role in cases of ischemic brain injury
Fil: Machado, Noelia Daiana. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Química Orgánica; Argentina. Universidad Nacional de Córdoba. Instituto de Investigación y Desarrollo en Ingeniería de Procesos y Química Aplicada. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación y Desarrollo en Ingeniería de Procesos y Química Aplicada; Argentina
Fil: Villena Armas, Gorka. Universidad de la Laguna. Departamento de Química Orgánica. Instituto Universitario de Bio-Orgánica "Antonio González"; España
Fil: Fernández, Mariana Adela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigaciones en Físico-química de Córdoba. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Instituto de Investigaciones en Físico-química de Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Química Orgánica; Argentina
Fil: Grijalvo, Santiago. Institute For Advanced Chemistry Of Catalonia; España. Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine; España
Fil: Díaz Díaz, David. Universidad de la Laguna. Departamento de Química Orgánica. Instituto Universitario de Bio-Orgánica "Antonio González"; España. Universitat Regensburg; Alemania - Materia
-
BLOOD BRAIN BARRIER
BRAIN
ISCHEMIA
NEUROPROTECTION
OXIDATIVE STRESS
POLYPHENOLS
RESVERATROL - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/172967
Ver los metadatos del registro completo
id |
CONICETDig_d0f7c0b45bf806b594b73061125a59e4 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/172967 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Neuroprotective Effects of Resveratrol in Ischemic Brain InjuryMachado, Noelia DaianaVillena Armas, GorkaFernández, Mariana AdelaGrijalvo, SantiagoDíaz Díaz, DavidBLOOD BRAIN BARRIERBRAINISCHEMIANEUROPROTECTIONOXIDATIVE STRESSPOLYPHENOLSRESVERATROLhttps://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1Cerebral ischemia represents the third cause of death and the first cause of disability inadults. This process results from decreasing cerebral blood flow levels as a result of the occlusionof a major cerebral artery. This restriction in blood supply generates low levels of oxygen andglucose, which leads to a decrease in the energy metabolism of the cell, producing inflammation, andfinally, neurological deterioration. Currently, blood restoration of flow is the only effective approachas a therapy in terms of ischemic stroke. However, a significant number of patients still have apoor prognosis, probably owing to the increase in the generation of reactive oxygen species (ROS)during the reperfusion of damaged tissue. Oxidative stress and inflammation can be avoided bymodulating mitochondrial function and have been identified as potential targets for the treatmentof cerebral ischemia. In recent years, the beneficial actions of flavonoids and polyphenols againstcerebrovascular diseases have been extensively investigated. The use of resveratrol (RSV) has beenshown to markedly decrease brain damage caused by ischemia in numerous studies. According toin vitro and in vivo experiments, there is growing evidence that RSV is involved in several pathways,including cAMP/AMPK/SIRT1 regulation, JAK/ERK/STAT signaling pathway modulation, TLR4signal transduction regulation, gut/brain axis modulation, GLUT3 up-regulation inhibition, neuronalautophagy activation, and de novo SUR1 expression inhibition. In this review, we summarize therecent outcomes based on the neuroprotective effect of RSV itself and RSV-loaded nanoparticlesin vitro and in vivo models focusing on such mechanisms of action as well as describing the potentialtherapeutic strategies in which RSV plays an active role in cases of ischemic brain injuryFil: Machado, Noelia Daiana. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Química Orgánica; Argentina. Universidad Nacional de Córdoba. Instituto de Investigación y Desarrollo en Ingeniería de Procesos y Química Aplicada. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación y Desarrollo en Ingeniería de Procesos y Química Aplicada; ArgentinaFil: Villena Armas, Gorka. Universidad de la Laguna. Departamento de Química Orgánica. Instituto Universitario de Bio-Orgánica "Antonio González"; EspañaFil: Fernández, Mariana Adela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigaciones en Físico-química de Córdoba. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Instituto de Investigaciones en Físico-química de Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Química Orgánica; ArgentinaFil: Grijalvo, Santiago. Institute For Advanced Chemistry Of Catalonia; España. Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine; EspañaFil: Díaz Díaz, David. Universidad de la Laguna. Departamento de Química Orgánica. Instituto Universitario de Bio-Orgánica "Antonio González"; España. Universitat Regensburg; AlemaniaMultidisciplinary Digital Publishing Institute2021-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/172967Machado, Noelia Daiana; Villena Armas, Gorka; Fernández, Mariana Adela; Grijalvo, Santiago; Díaz Díaz, David; Neuroprotective Effects of Resveratrol in Ischemic Brain Injury; Multidisciplinary Digital Publishing Institute; NeuroSci; 2; 3; 9-2021; 305-3192673-4087CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/ 10.3390/neurosci2030022info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/2673-4087/2/3/22info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:45:25Zoai:ri.conicet.gov.ar:11336/172967instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:45:25.952CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Neuroprotective Effects of Resveratrol in Ischemic Brain Injury |
title |
Neuroprotective Effects of Resveratrol in Ischemic Brain Injury |
spellingShingle |
Neuroprotective Effects of Resveratrol in Ischemic Brain Injury Machado, Noelia Daiana BLOOD BRAIN BARRIER BRAIN ISCHEMIA NEUROPROTECTION OXIDATIVE STRESS POLYPHENOLS RESVERATROL |
title_short |
Neuroprotective Effects of Resveratrol in Ischemic Brain Injury |
title_full |
Neuroprotective Effects of Resveratrol in Ischemic Brain Injury |
title_fullStr |
Neuroprotective Effects of Resveratrol in Ischemic Brain Injury |
title_full_unstemmed |
Neuroprotective Effects of Resveratrol in Ischemic Brain Injury |
title_sort |
Neuroprotective Effects of Resveratrol in Ischemic Brain Injury |
dc.creator.none.fl_str_mv |
Machado, Noelia Daiana Villena Armas, Gorka Fernández, Mariana Adela Grijalvo, Santiago Díaz Díaz, David |
author |
Machado, Noelia Daiana |
author_facet |
Machado, Noelia Daiana Villena Armas, Gorka Fernández, Mariana Adela Grijalvo, Santiago Díaz Díaz, David |
author_role |
author |
author2 |
Villena Armas, Gorka Fernández, Mariana Adela Grijalvo, Santiago Díaz Díaz, David |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
BLOOD BRAIN BARRIER BRAIN ISCHEMIA NEUROPROTECTION OXIDATIVE STRESS POLYPHENOLS RESVERATROL |
topic |
BLOOD BRAIN BARRIER BRAIN ISCHEMIA NEUROPROTECTION OXIDATIVE STRESS POLYPHENOLS RESVERATROL |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Cerebral ischemia represents the third cause of death and the first cause of disability inadults. This process results from decreasing cerebral blood flow levels as a result of the occlusionof a major cerebral artery. This restriction in blood supply generates low levels of oxygen andglucose, which leads to a decrease in the energy metabolism of the cell, producing inflammation, andfinally, neurological deterioration. Currently, blood restoration of flow is the only effective approachas a therapy in terms of ischemic stroke. However, a significant number of patients still have apoor prognosis, probably owing to the increase in the generation of reactive oxygen species (ROS)during the reperfusion of damaged tissue. Oxidative stress and inflammation can be avoided bymodulating mitochondrial function and have been identified as potential targets for the treatmentof cerebral ischemia. In recent years, the beneficial actions of flavonoids and polyphenols againstcerebrovascular diseases have been extensively investigated. The use of resveratrol (RSV) has beenshown to markedly decrease brain damage caused by ischemia in numerous studies. According toin vitro and in vivo experiments, there is growing evidence that RSV is involved in several pathways,including cAMP/AMPK/SIRT1 regulation, JAK/ERK/STAT signaling pathway modulation, TLR4signal transduction regulation, gut/brain axis modulation, GLUT3 up-regulation inhibition, neuronalautophagy activation, and de novo SUR1 expression inhibition. In this review, we summarize therecent outcomes based on the neuroprotective effect of RSV itself and RSV-loaded nanoparticlesin vitro and in vivo models focusing on such mechanisms of action as well as describing the potentialtherapeutic strategies in which RSV plays an active role in cases of ischemic brain injury Fil: Machado, Noelia Daiana. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Química Orgánica; Argentina. Universidad Nacional de Córdoba. Instituto de Investigación y Desarrollo en Ingeniería de Procesos y Química Aplicada. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación y Desarrollo en Ingeniería de Procesos y Química Aplicada; Argentina Fil: Villena Armas, Gorka. Universidad de la Laguna. Departamento de Química Orgánica. Instituto Universitario de Bio-Orgánica "Antonio González"; España Fil: Fernández, Mariana Adela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigaciones en Físico-química de Córdoba. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Instituto de Investigaciones en Físico-química de Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Química Orgánica; Argentina Fil: Grijalvo, Santiago. Institute For Advanced Chemistry Of Catalonia; España. Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine; España Fil: Díaz Díaz, David. Universidad de la Laguna. Departamento de Química Orgánica. Instituto Universitario de Bio-Orgánica "Antonio González"; España. Universitat Regensburg; Alemania |
description |
Cerebral ischemia represents the third cause of death and the first cause of disability inadults. This process results from decreasing cerebral blood flow levels as a result of the occlusionof a major cerebral artery. This restriction in blood supply generates low levels of oxygen andglucose, which leads to a decrease in the energy metabolism of the cell, producing inflammation, andfinally, neurological deterioration. Currently, blood restoration of flow is the only effective approachas a therapy in terms of ischemic stroke. However, a significant number of patients still have apoor prognosis, probably owing to the increase in the generation of reactive oxygen species (ROS)during the reperfusion of damaged tissue. Oxidative stress and inflammation can be avoided bymodulating mitochondrial function and have been identified as potential targets for the treatmentof cerebral ischemia. In recent years, the beneficial actions of flavonoids and polyphenols againstcerebrovascular diseases have been extensively investigated. The use of resveratrol (RSV) has beenshown to markedly decrease brain damage caused by ischemia in numerous studies. According toin vitro and in vivo experiments, there is growing evidence that RSV is involved in several pathways,including cAMP/AMPK/SIRT1 regulation, JAK/ERK/STAT signaling pathway modulation, TLR4signal transduction regulation, gut/brain axis modulation, GLUT3 up-regulation inhibition, neuronalautophagy activation, and de novo SUR1 expression inhibition. In this review, we summarize therecent outcomes based on the neuroprotective effect of RSV itself and RSV-loaded nanoparticlesin vitro and in vivo models focusing on such mechanisms of action as well as describing the potentialtherapeutic strategies in which RSV plays an active role in cases of ischemic brain injury |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-09 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/172967 Machado, Noelia Daiana; Villena Armas, Gorka; Fernández, Mariana Adela; Grijalvo, Santiago; Díaz Díaz, David; Neuroprotective Effects of Resveratrol in Ischemic Brain Injury; Multidisciplinary Digital Publishing Institute; NeuroSci; 2; 3; 9-2021; 305-319 2673-4087 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/172967 |
identifier_str_mv |
Machado, Noelia Daiana; Villena Armas, Gorka; Fernández, Mariana Adela; Grijalvo, Santiago; Díaz Díaz, David; Neuroprotective Effects of Resveratrol in Ischemic Brain Injury; Multidisciplinary Digital Publishing Institute; NeuroSci; 2; 3; 9-2021; 305-319 2673-4087 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/ 10.3390/neurosci2030022 info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/2673-4087/2/3/22 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute |
publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268730073022464 |
score |
13.13397 |